Back
Open Access

Five years of PCSK9i: Lessons from practice, which patients do benefit most?

Session: PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities
Topic: Drug therapy
Speaker: Professor E. Stroes (Amsterdam, NL)
Organised by PACE-CME, supported by Amgen and Sanofi in the form of an educational grant
Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
39 presentations
0 follower

4 more presentations in this session

Introduction.

Speaker: Professor J. Kastelein (Amsterdam, NL)

Access
Video
Thumbnail

One year after: what are the implications of the new The ESC/EAS LDL-c Guidelines for PCSK9i?

Speaker: Professor F. Mach (Geneva, CH)

Access
Video
Thumbnail

Time to reduce the implementation gaps-the role of PCSK9i in routine practice

Speaker: Professor K. Ray (London, GB)

Access
Video
Thumbnail

Discussion.

Speaker: Professor J. Kastelein (Amsterdam, NL)

Access
Video
Thumbnail

Access the full session

PCSK9i & LDL-c: Guidelines, Practice & Innovation: Review of facts and opportunities

Speakers: Professor E. Stroes, Professor J. Kastelein, Professor F. Mach, Professor K. Ray, Professor J. Kastelein
Access
Video
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb